Evidence map›Paper›PMID 33821873›Full record

ArticleGenetics and molecular biology2021

Gene expression evaluation of antioxidant enzymes in patients with hepatocellular carcinoma: RT-qPCR and bioinformatic analyses.

Andressa de Freitas Alves, Ana Carolina de Moura, Huander Felipe Andreolla, Ana Beatriz Gorini da Veiga, Marilu Fiegenbaum, Márcia Giovenardi, Silvana Almeida

Open access · goldAbstract read
In one paragraph

Article in Genetics and molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Effects of the Polar Fraction ofInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andressa de Freitas AlvesUniversidade Federal de Ciências da Saúde de Porto Alegre, Programa de Pós-graduação em Biociências, Porto Alegre, RS, Brazil.
Ana Carolina de MouraUniversidade Federal de Ciências da Saúde de Porto Alegre, Programa de Pós-graduação em Biociências, Porto Alegre, RS, Brazil.
Huander Felipe AndreollaUniversidade Franciscana, Santa Maria, RS, Brazil.
Ana Beatriz Gorini da VeigaUniversidade Federal de Ciências da Saúde de Porto Alegre, Programa de Pós-graduação em Biociências, Porto Alegre, RS, Brazil.ORCID http://orcid.org/0000-0003-1462-5506
Marilu FiegenbaumUniversidade Federal de Ciências da Saúde de Porto Alegre, Programa de Pós-graduação em Biociências, Porto Alegre, RS, Brazil.ORCID http://orcid.org/0000-0002-5408-2078
Márcia GiovenardiUniversidade Federal de Ciências da Saúde de Porto Alegre, Programa de Pós-graduação em Biociências, Porto Alegre, RS, Brazil.
Silvana AlmeidaUniversidade Federal de Ciências da Saúde de Porto Alegre, Programa de Pós-graduação em Biociências, Porto Alegre, RS, Brazil.ORCID http://orcid.org/0000-0001-7959-3723
Universidade Federal de Ciências da Saúde de Porto Alegre · BRUniversidade Franciscana · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Any condition leading to chronic liver disease is a potential oncogenic agent for hepatocellular carcinoma (HCC). Alterations in the expression of antioxidant enzymes could alter the redox balance. Our aim was to evaluate the expression of the genes GPX1, GPX4, SEP15, SELENOP, SOD1, SOD2, GSR, CAT, and NFE2L2 in patients with HCC. Differential gene expression analysis was performed using RNA-Seq data from the TCGA and GTEx databases, and RT-qPCR data from HCC patient samples. Bioinformatic analysis revealed significant differential expression in most genes. GPX4 expression was significantly increased (p=0.02), while SOD2 expression was significantly decreased (p=0.04) in experimental data. In TCGA samples, alpha-fetoprotein levels (mg/dL) were negatively correlated with the expression of SEP15 (p<0.001), SELENOP (p<0.001), SOD1 (p<0.001), SOD2 (p<0.001), CAT (p<0.001), and NFE2L2 (p=0.004). Alpha-fetoprotein levels were positively correlated with the expression of GPX4 (p=0.02) and SELENOP (p=0.01) in the experimental data. Low expression of GPX1 (p=0.006), GPX4 (p=0.01), SELENOP (p=0.006), SOD1 (p=0.007), CAT (p<0.001), and NFE2L2 (p<0.001), and higher levels of GSR, were associated with low overall survival at 12 months. These results suggest a significant role for these antioxidant enzymes in HCC pathogenesis and severity.

Identifiers

PMID33821873
PMCPMC8022359
OpenAlexW3142785001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.